Cardlytics (CDLX) Stock Price
Cardlytics Price
Over the last 9 years Cardlytics grew revenue by 15.2% annually, reaching 278.30 M USD. For Cardlytics, the net margin of -68.0% is down versus -29.6% a few years ago. The consensus 12-month price target for Cardlytics is 1.53 USD, about 63.7% below where the stock trades today. Of 10 analysts, 0 rate the stock a buy — an overall Hold consensus. The stock trades about 2% above its 52-week low.
Cardlytics stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Cardlytics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cardlytics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cardlytics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Cardlytics Price |
|---|---|
| 7/14/2026 | 4.22 USD |
| 7/13/2026 | 4.15 USD |
| 7/10/2026 | 4.32 USD |
| 7/9/2026 | 4.16 USD |
| 7/8/2026 | 4.14 USD |
| 7/7/2026 | 4.26 USD |
| 7/6/2026 | 4.54 USD |
| 7/2/2026 | 4.47 USD |
| 7/1/2026 | 4.44 USD |
| 6/30/2026 | 4.49 USD |
| 6/29/2026 | 4.87 USD |
| 6/26/2026 | 4.71 USD |
| 6/25/2026 | 4.97 USD |
| 6/24/2026 | 5.36 USD |
| 6/23/2026 | 5.34 USD |
| 6/22/2026 | 4.95 USD |
| 6/18/2026 | 5.20 USD |
| 6/17/2026 | 4.99 USD |
| 6/16/2026 | 5.24 USD |
| 6/15/2026 | 5.36 USD |
| 6/12/2026 | 5.41 USD |
| 6/11/2026 | 5.12 USD |
| 6/10/2026 | 4.83 USD |
| 6/9/2026 | 4.76 USD |
| 6/8/2026 | 5.20 USD |
| 6/5/2026 | 5.98 USD |
| 6/4/2026 | 6.10 USD |
| 6/3/2026 | 6.50 USD |
| 6/2/2026 | 6.52 USD |
| 6/1/2026 | 6.77 USD |
| 5/29/2026 | 6.75 USD |
| 5/28/2026 | 7.13 USD |
| 5/27/2026 | 7.14 USD |
| 5/26/2026 | 7.21 USD |
| 5/22/2026 | 6.93 USD |
| 5/21/2026 | 7.29 USD |
| 5/20/2026 | 7.25 USD |
| 5/19/2026 | 5.96 USD |
| 5/18/2026 | 6.06 USD |
| 5/15/2026 | 6.32 USD |
| 5/14/2026 | 6.47 USD |
| 5/13/2026 | 6.65 USD |
| 5/12/2026 | 6.75 USD |
| 5/11/2026 | 6.51 USD |
| 5/8/2026 | 6.40 USD |
| 5/7/2026 | 7.82 USD |
| 5/6/2026 | 7.95 USD |
| 5/5/2026 | 8.39 USD |
| 5/4/2026 | 8.80 USD |
| 5/1/2026 | 9.15 USD |
| 4/30/2026 | 8.97 USD |
| 4/29/2026 | 9.00 USD |
| 4/28/2026 | 9.05 USD |
| 4/27/2026 | 9.01 USD |
| 4/24/2026 | 9.30 USD |
| 4/23/2026 | 9.70 USD |
| 4/22/2026 | 9.90 USD |
| 4/21/2026 | 9.72 USD |
| 4/20/2026 | 10.20 USD |
| 4/17/2026 | 10.10 USD |
| 4/16/2026 | 9.52 USD |
| 4/15/2026 | 10.10 USD |
| 4/14/2026 | 9.66 USD |
| 4/13/2026 | 9.80 USD |
| 4/10/2026 | 8.96 USD |
| 4/9/2026 | 9.69 USD |
| 4/8/2026 | 10.50 USD |
| 4/7/2026 | 11.50 USD |
| 4/6/2026 | 11.80 USD |
| 4/2/2026 | 11.30 USD |
| 4/1/2026 | 10.00 USD |
| 3/31/2026 | 10.50 USD |
| 3/30/2026 | 8.99 USD |
| 3/27/2026 | 9.32 USD |
| 3/26/2026 | 10.10 USD |
| 3/25/2026 | 10.60 USD |
| 3/24/2026 | 9.39 USD |
| 3/23/2026 | 9.12 USD |
| 3/20/2026 | 8.25 USD |
| 3/19/2026 | 7.59 USD |
| 3/18/2026 | 7.25 USD |
| 3/17/2026 | 7.30 USD |
| 3/16/2026 | 6.97 USD |
| 3/13/2026 | 6.75 USD |
| 3/12/2026 | 6.69 USD |
| 3/11/2026 | 7.03 USD |
| 3/10/2026 | 7.04 USD |
| 3/9/2026 | 7.38 USD |
| 3/6/2026 | 7.80 USD |
| 3/5/2026 | 8.16 USD |
| 3/4/2026 | 9.00 USD |
| 3/3/2026 | 8.29 USD |
| 3/2/2026 | 8.28 USD |
| 2/27/2026 | 8.64 USD |
| 2/26/2026 | 8.81 USD |
| 2/25/2026 | 8.82 USD |
| 2/24/2026 | 8.68 USD |
| 2/23/2026 | 8.55 USD |
| 2/20/2026 | 9.08 USD |
| 2/19/2026 | 8.86 USD |
| 2/18/2026 | 9.31 USD |
| 2/17/2026 | 9.11 USD |
| 2/13/2026 | 9.33 USD |
| 2/12/2026 | 10.10 USD |
| 2/11/2026 | 8.87 USD |
| 2/10/2026 | 9.31 USD |
| 2/9/2026 | 9.34 USD |
| 2/6/2026 | 9.06 USD |
| 2/5/2026 | 8.65 USD |
| 2/4/2026 | 8.37 USD |
| 2/3/2026 | 8.82 USD |
| 2/2/2026 | 9.42 USD |
| 1/30/2026 | 9.69 USD |
| 1/29/2026 | 10.20 USD |
| 1/28/2026 | 10.30 USD |
| 1/27/2026 | 11.10 USD |
| 1/26/2026 | 11.50 USD |
| 1/23/2026 | 12.10 USD |
| 1/22/2026 | 12.00 USD |
| 1/21/2026 | 11.70 USD |
| 1/20/2026 | 11.50 USD |
| 1/16/2026 | 12.00 USD |
| 1/15/2026 | 12.40 USD |
| 1/14/2026 | 12.90 USD |
| 1/13/2026 | 12.20 USD |
| 1/12/2026 | 12.90 USD |
| 1/9/2026 | 13.50 USD |
| 1/8/2026 | 15.20 USD |
| 1/7/2026 | 14.30 USD |
| 1/6/2026 | 13.10 USD |
| 1/5/2026 | 12.40 USD |
| 1/2/2026 | 11.20 USD |
| 12/31/2025 | 11.50 USD |
| 12/30/2025 | 11.50 USD |
| 12/29/2025 | 11.60 USD |
| 12/26/2025 | 11.85 USD |
| 12/24/2025 | 12.20 USD |
| 12/23/2025 | 10.80 USD |
| 12/22/2025 | 10.30 USD |
| 12/19/2025 | 10.30 USD |
| 12/18/2025 | 10.10 USD |
| 12/17/2025 | 9.62 USD |
| 12/16/2025 | 10.60 USD |
| 12/15/2025 | 10.40 USD |
| 12/12/2025 | 10.80 USD |
| 12/11/2025 | 11.70 USD |
| 12/10/2025 | 11.80 USD |
| 12/9/2025 | 11.90 USD |
| 12/8/2025 | 11.00 USD |
| 12/5/2025 | 11.00 USD |
| 12/4/2025 | 12.10 USD |
| 12/3/2025 | 12.30 USD |
| 12/2/2025 | 10.80 USD |
| 12/1/2025 | 11.90 USD |
| 11/28/2025 | 12.40 USD |
| 11/26/2025 | 12.30 USD |
| 11/25/2025 | 12.00 USD |
| 11/24/2025 | 12.20 USD |
| 11/21/2025 | 11.40 USD |
| 11/20/2025 | 10.90 USD |
| 11/19/2025 | 12.10 USD |
| 11/18/2025 | 12.30 USD |
| 11/17/2025 | 12.70 USD |
| 11/14/2025 | 13.90 USD |
| 11/13/2025 | 14.40 USD |
| 11/12/2025 | 15.00 USD |
| 11/11/2025 | 14.70 USD |
| 11/10/2025 | 14.30 USD |
| 11/7/2025 | 14.10 USD |
| 11/6/2025 | 12.60 USD |
| 11/5/2025 | 17.60 USD |
| 11/4/2025 | 17.35 USD |
| 11/3/2025 | 19.00 USD |
| 10/31/2025 | 19.40 USD |
| 10/30/2025 | 19.00 USD |
| 10/29/2025 | 19.40 USD |
| 10/28/2025 | 19.90 USD |
| 10/27/2025 | 20.70 USD |
| 10/24/2025 | 20.30 USD |
| 10/23/2025 | 20.70 USD |
| 10/22/2025 | 19.20 USD |
| 10/21/2025 | 18.90 USD |
| 10/20/2025 | 19.50 USD |
| 10/17/2025 | 18.80 USD |
| 10/16/2025 | 20.00 USD |
| 10/15/2025 | 21.50 USD |
| 10/14/2025 | 21.20 USD |
| 10/13/2025 | 19.30 USD |
| 10/10/2025 | 19.10 USD |
| 10/9/2025 | 21.40 USD |
| 10/8/2025 | 23.20 USD |
| 10/7/2025 | 22.75 USD |
| 10/6/2025 | 25.80 USD |
| 10/3/2025 | 23.70 USD |
| 10/2/2025 | 23.70 USD |
| 10/1/2025 | 23.60 USD |
| 9/30/2025 | 24.30 USD |
| 9/29/2025 | 26.40 USD |
| 9/26/2025 | 28.20 USD |
| 9/25/2025 | 23.80 USD |
| 9/24/2025 | 26.40 USD |
| 9/23/2025 | 20.90 USD |
| 9/22/2025 | 21.50 USD |
| 9/19/2025 | 24.30 USD |
| 9/18/2025 | 27.55 USD |
| 9/17/2025 | 14.30 USD |
| 9/16/2025 | 15.30 USD |
| 9/15/2025 | 12.70 USD |
| 9/12/2025 | 11.20 USD |
| 9/11/2025 | 11.50 USD |
| 9/10/2025 | 9.36 USD |
| 9/9/2025 | 9.80 USD |
| 9/8/2025 | 9.10 USD |
| 9/5/2025 | 9.32 USD |
| 9/4/2025 | 9.21 USD |
| 9/3/2025 | 8.90 USD |
| 9/2/2025 | 10.10 USD |
| 8/29/2025 | 10.20 USD |
| 8/28/2025 | 10.60 USD |
| 8/27/2025 | 10.30 USD |
| 8/26/2025 | 10.30 USD |
| 8/25/2025 | 10.90 USD |
| 8/22/2025 | 11.10 USD |
| 8/21/2025 | 10.10 USD |
| 8/20/2025 | 10.50 USD |
| 8/19/2025 | 11.00 USD |
| 8/18/2025 | 11.25 USD |
| 8/15/2025 | 12.10 USD |
| 8/14/2025 | 12.10 USD |
| 8/13/2025 | 13.10 USD |
| 8/12/2025 | 12.50 USD |
| 8/11/2025 | 11.00 USD |
| 8/8/2025 | 11.80 USD |
| 8/7/2025 | 13.00 USD |
| 8/6/2025 | 17.60 USD |
| 8/5/2025 | 18.40 USD |
| 8/4/2025 | 19.60 USD |
| 8/1/2025 | 18.80 USD |
| 7/31/2025 | 20.40 USD |
| 7/30/2025 | 20.50 USD |
| 7/29/2025 | 20.80 USD |
| 7/28/2025 | 23.50 USD |
| 7/25/2025 | 24.50 USD |
| 7/24/2025 | 27.05 USD |
| 7/23/2025 | 31.20 USD |
| 7/22/2025 | 28.50 USD |
| 7/21/2025 | 20.30 USD |
| 7/18/2025 | 16.80 USD |
| 7/17/2025 | 16.80 USD |
Cardlytics Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Cardlytics Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.00 | 112.00 | 130.00 | 150.00 | 210.00 | 186.00 | 267.00 | 298.00 | 309.00 | 278.00 | 236.00 | 223.00 | 328.00 |
| – | 45.45 | 16.07 | 15.38 | 40.00 | -11.43 | 43.55 | 11.61 | 3.69 | -10.03 | -15.11 | -5.51 | 47.09 |
| 37.66 | 42.86 | 44.62 | 44.00 | 45.24 | 43.55 | 48.31 | 49.33 | 51.13 | 53.96 | 53.96 | 53.96 | 53.96 |
| 29.00 | 48.00 | 58.00 | 66.00 | 95.00 | 81.00 | 129.00 | 147.00 | 158.00 | 150.00 | 127.34 | 120.32 | 176.98 |
| -41.00 | -76.00 | -25.00 | -53.00 | -17.00 | -55.00 | -128.00 | -465.00 | -134.00 | -189.00 | -27.00 | -17.00 | 2.00 |
| – | 85.37 | -67.11 | 112.00 | -67.92 | 223.53 | 132.73 | 263.28 | -71.18 | 41.04 | -85.71 | -37.04 | -111.76 |
| 19.50 | 19.50 | 20.00 | 19.10 | 23.70 | 27.20 | 32.20 | 33.40 | 36.49 | 48.36 | 48.36 | 48.36 | 48.36 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Cardlytics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cardlytics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cardlytics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Cardlytics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cardlytics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Cardlytics stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Cardlytics Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Cardlytics business model & stock analysis
Cardlytics SWOT Analysis
Strengths
Cardlytics Inc has several strengths that contribute to its success in the market. Firstly, the company has developed a unique technology platform that enables it to analyze consumer purchase data from financial institutions. This gives Cardlytics a competitive advantage in understanding consumer behaviors and preferences.
Another strength of Cardlytics is its extensive network of partnerships with major banks and financial institutions. This allows the company to access large amounts of valuable data, further enhancing its ability to provide targeted advertising and insights to its clients.
Additionally, Cardlytics benefits from its strong reputation and established presence in the industry. Its proven track record of delivering results to advertisers and financial institutions builds trust and loyalty among its customers.
Weaknesses
Despite its strengths, Cardlytics Inc also faces some weaknesses that need to be addressed. One weakness is its dependence on its partnership network for data. Any disruptions or termination of these partnerships could significantly impact the company's ability to access and analyze consumer purchase data.
Another weakness is the potential privacy concerns associated with analyzing and utilizing consumer financial data. Cardlytics must ensure it has strong data security measures and maintains compliance with privacy regulations to address these concerns and maintain consumer trust.
Opportunities
Cardlytics Inc has several opportunities for growth and expansion. One opportunity is the increasing demand for personalized advertising and targeted marketing campaigns. As consumers expect more tailored experiences, Cardlytics can capitalize on this trend by utilizing its data analytics capabilities to deliver relevant advertisements to consumers.
Another opportunity lies in expanding its partnerships to reach more financial institutions and markets globally. By forming strategic alliances, Cardlytics can expand its data pool and increase its market reach, opening up new revenue streams.
Threats
There are also threats that Cardlytics Inc needs to consider in its business operations. One threat is the increasing competition in the data analytics and digital advertising industry. As more companies enter the market and offer similar services, Cardlytics must differentiate itself and continuously innovate to maintain its competitive edge.
Additionally, regulatory changes or new privacy laws could pose a threat to Cardlytics' data collection and utilization practices. Adapting to evolving regulations and ensuring compliance will be critical to mitigating this threat and avoiding potential legal and reputational consequences.
Cardlytics Segments
Cardlytics Revenue by Segment (1/5)
3 Years
5 Years
10 Years
25 Years
Max
Details
Cardlytics Revenue by Segment (2/5)
Max
Details
Cardlytics Revenue by Segment (3/5)
3 Years
5 Years
Max
Details
Cardlytics Revenue by Segment (4/5)
Max
Details
Cardlytics Revenue by Segment (5/5)
Max
Details
Cardlytics Revenue by Region
3 Years
5 Years
Max
Details
Cardlytics Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Cardlytics historical P/E ratio, EBIT multiple, and P/S ratio
Cardlytics annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Cardlytics shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Cardlytics forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 0.00 % |
| Buy | 0.00 % (0) |
| Hold | 60.00 % (6) |
| Sell | 40.00 % (4) |
| 12M Price Target | 1.53 |
| Last Price | 4.30 |
| Currency | USD |
| 12M Return Potential | -64.42 % |
| LTM Return | 0 % |
Cardlytics Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 8/4/2026 | -1.38USD | 37.74 MUSD | 2026 Q2 |
| 5/6/2026 | -0.22USD | 37.94 MUSD | 2026 Q1 |
| 5/5/2026 | -0.22USD | 37.94 MUSD | 2026 Q1 |
| 3/4/2026 | -0.07USD | 55.54 MUSD | 2025 Q4 |
| 3/3/2026 | -0.07USD | 55.54 MUSD | 2025 Q4 |
| 11/6/2024 | 0.03USD | 87.35 MUSD | 2024 Q3 |
| 5/2/2024 | -0.24USD | 67.79 MUSD | 2024 Q1 |
| 2/28/2024 | 0.07USD | 86.40 MUSD | 2023 Q4 |
| 7/31/2023 | -0.38USD | 78.63 MUSD | 2023 Q2 |
| 5/1/2023 | -0.48USD | 69.85 MUSD | 2023 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Cardlytics stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Cardlytics shareholder structure
| % | Name |
|---|---|
9.61537% | |
4.47079% | |
3.05216% | |
2.25459% | |
2.14204% | |
2.13651% |
Cardlytics Executives and Management Board
Mr. Amit Gupta
(53)Chief Executive Officer, Director · since 2023
Ms. Alexis Desieno
(41)Chief Financial Officer
Mr. Nick Lynton
(42)Chief Legal and Privacy Officer
Mr. Andre Fernandez
(56)Independent Director
Mr. Jon Francis
(53)Independent Director
Frequently asked questions about Cardlytics
The business model of Cardlytics Inc revolves around providing a unique advertising platform that allows marketers to reach and engage with targeted consumers through their bank’s digital channels. By partnering with financial institutions, Cardlytics enables advertisers to deliver relevant offers and rewards to consumers based on their purchase behavior and spending patterns. Through its proprietary technology and extensive data insights, Cardlytics helps advertisers optimize their marketing campaigns and drive measurable results. Cardlytics’ business model focuses on generating revenue through advertising and transactional fees.
Cardlytics stock
Cardlytics Peer Group
Cardlytics Ticker
Cardlytics FIGI
All fundamentals and in-depth analysis of Cardlytics
Our stock analysis for Cardlytics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardlytics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.